174 related articles for article (PubMed ID: 17564320)
21. Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome.
Yamada Y; Endo S; Kasai T; Koike S; Takakuwa T; Inoue Y; Niimi M; Endo Y; Wakabayashi G; Inada K
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):92-104. PubMed ID: 9644723
[TBL] [Abstract][Full Text] [Related]
22. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
[TBL] [Abstract][Full Text] [Related]
23. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis.
Tokushige K; Yamaguchi N; Ikeda I; Hashimoto E; Yamauchi K; Hayashi N
Am J Gastroenterol; 2000 Aug; 95(8):2040-6. PubMed ID: 10950055
[TBL] [Abstract][Full Text] [Related]
24. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
Pignataro L; Arisi E; Sambataro G; Corsi MM
J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
[TBL] [Abstract][Full Text] [Related]
25. Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):271-6. PubMed ID: 17899083
[TBL] [Abstract][Full Text] [Related]
26. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
Tagami A; Ohnishi H; Hughes RD
Hepatogastroenterology; 2003; 50(51):742-5. PubMed ID: 12828076
[TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure.
Singhal S; Chakravarty A; Das BC; Kar P
Biomarkers; 2009 Aug; 14(5):347-53. PubMed ID: 19505222
[TBL] [Abstract][Full Text] [Related]
28. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
Song le H; Binh VQ; Duy DN; Bock TC; Kremsner PG; Luty AJ; Mavoungou E
J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
[TBL] [Abstract][Full Text] [Related]
29. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
Jun EJ; Han JY; Sun HS
Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
[TBL] [Abstract][Full Text] [Related]
31. Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies.
Hazar V; Berber Z; Pestereli E; Coskun M; Yesilipek A; Karpuzoglu G; Yegin O
Pediatr Hematol Oncol; 2005; 22(3):247-56. PubMed ID: 16020109
[TBL] [Abstract][Full Text] [Related]
32. [Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis].
Yuan BJ; Liu ZZ; Ding XR; Zou JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):96-8. PubMed ID: 16600114
[TBL] [Abstract][Full Text] [Related]
33. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study.
Huttunen R; Syrjänen J; Vuento R; Laine J; Hurme M; Aittoniemi J
J Infect; 2012 Mar; 64(3):276-81. PubMed ID: 22207003
[TBL] [Abstract][Full Text] [Related]
35. Soluble Fas ligand expression in the ocular fluids of uveitis patients.
Sotozono C; Sano Y; Suzuki T; Tada R; Ikeda T; Nagata S; Kinoshita S
Curr Eye Res; 2000 Jan; 20(1):54-7. PubMed ID: 10611715
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease.
Enjoji M; Yamaguchi K; Nakashima M; Ohta S; Kotoh K; Fukushima M; Kuniyoshi M; Tanaka M; Nakamuta M; Watanabe T; Nawata H
Liver Int; 2004 Aug; 24(4):330-4. PubMed ID: 15287856
[TBL] [Abstract][Full Text] [Related]
37. Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
Pelli N; Floreani A; Torre F; Delfino A; Baragiotta A; Contini P; Basso M; Picciotto A
Clin Exp Immunol; 2007 Apr; 148(1):85-9. PubMed ID: 17302732
[TBL] [Abstract][Full Text] [Related]
38. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
[TBL] [Abstract][Full Text] [Related]
39. Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients.
Papathanassoglou ED; Movnihan JA; Dafni O; Mantzoros CS; Ackerman MH
Biol Res Nurs; 2003 Oct; 5(2):129-41. PubMed ID: 14531217
[TBL] [Abstract][Full Text] [Related]
40. The sFas/sFasL ratio as a novel marker of inflammation in children with chronic kidney disease.
Musiał K; Zwolińska D
Clin Chim Acta; 2012 Dec; 414():7-11. PubMed ID: 22898262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
